Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dendritic Cell Vaccine For Malignant Glioma and Glioblastoma Multiforme in Adult and Pediatric Subjects

NCT01808820 is registered in ClinicalTrials.gov with Macarena De La Fuente, MD as lead sponsor.

NCT NCT01808820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01808820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dendritic Cell Vaccine For Malignant Glioma and Glioblastoma Multiforme in Adult and Pediatric Subjects
Lead sponsor
Macarena De La Fuente, MD
Phase
Phase 1
Overall status
Completed
Start date
August 21, 2013
Completion date
July 16, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, glioblastoma multiforme, high grade glioma, malignant glioma